A detailed history of Sc&H Financial Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Sc&H Financial Advisors, Inc. holds 263 shares of LLY stock, worth $269,648. This represents 0.04% of its overall portfolio holdings.

Number of Shares
263
Previous 261 0.77%
Holding current value
$269,648
Previous $203,000 1.48%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$625.65 - $812.69 $1,251 - $1,625
2 Added 0.77%
263 $200,000
Q2 2025

Jul 16, 2025

BUY
$713.71 - $898.95 $186,278 - $234,625
261 New
261 $203,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $974B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Sc&H Financial Advisors, Inc. Portfolio

Follow Sc&H Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sc&H Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sc&H Financial Advisors, Inc. with notifications on news.